We help pharma companies

Get BETTER drugs to market

A new landscape of information

In your clinical trial, you want to know more about your drug's efficacy, and you want to know it sooner. AIQ products make your drug development studies faster and more informative, especially when you are targeting early disease or exploring sequence/combination approaches. AIQ broadens the information landscape available to pharma companies, using data that are reliable, proven, and actionable.

How do our solutions help you?

Competition in the oncology drug space is intense. The costs of drug development are high. Every day, you're working to make decisions that will allow you to grow market share, decrease your expenses, capture patients at earlier disease stages, and improve drug candidate success rates. Our platform provides intelligence, analytics, and insights you cannot get from other systems or tools. We help you win in your target markets while delivering better therapies for patients.

in early-phase trials
01

Optimize dose-finding

AIQ products provide precise, quantitative evaluation of treatment response. This information can be used to determine the optimal dose, especially when dosing to toxicity is not ideal.

02

Increase understanding of pharmacodynamic effects

AIQ technology provides detailed data on response heterogeneity, timing, sequence, etc., that are not available with other tools.

03

Allow more informative go/no-go decision making

With AIQ technology, pharma companies get detailed knowledge of drug candidate efficacy faster. AIQ products also enable imaging-directed biopsies to improve understanding of how a treatment is or is not working.

in Later-phase trials
01

Enable patient enrichment

AIQ products help rapidly identify sub-optimal responders and determine which may benefit from a more aggressive approach (e.g., re-randomization to a different or combination therapy).

02

Enable newer strategies to maximize benefit

When should a clinician stop a particular drug therapy? AIQ products can help prove continued drug efficacy beyond the point of clinical disease progression, informing strategies other than discontinuing a current therapy.

03

Provide a new and more efficient surrogacy marker

AIQ technology can detect disease and measure treatment response sooner, more quickly, and more precisely than other tools. We envision that these tools will offer value as better surrogacy markers for drug trials.

01

Increase understanding of disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. 

Learn more ›

02

Make better treatment decisions

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. 

Learn more ›

03

Assess treatment effectiveness earlier

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. 

Learn more ›

04

Extend your patients' lives

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. 

Learn more ›

Interested in knowing more? We'd love to show you our revolutionary platform.

Contact us for a demo